| [1] |
Yu Lan, Chen Shuangshuang, Wang Nenhan, Tian Lili, Zhao Yanfeng, Fan Ruifang, Liu Haican, Li Chuanyou, Dai Xiaowei.
Consistency between phenotypic resistance to fluoroquinolones and genetic mutations in rifampicin resistant Mycobacterium tuberculosis strains
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 942-950.
|
| [2] |
Xu Yu, He Yukun, Zhou Dexun, Zhang Pingji.
Analysis of the distribution characteristics of microbial communities in the lower respiratory tract of pulmonary tuberculosis patients based on metagenomic sequencing
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 634-640.
|
| [3] |
Yang Jing, Xiao Lijuan, Fang Tanwei.
Development strategy and prospect of tuberculosis mRNA vaccines
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 590-595.
|
| [4] |
Li Junli, Guo Xiaonan, Liang Yan, He Pu, Li Xiaochi, Zhao Aihua, Du Weixin, Wu Xueqiong, Zhu Bingdong, Xu Miao.
Research advances and breakthroughs in tuberculosis vaccine
[J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1171-1184.
|
| [5] |
Shang Yaomin, Zhou Xiaolei, Xue Yunling, Leng Xia.
Effect of microcard combined with vitamin D on the balance of CD4+ T cell subsets in initially treated patients with smear positive pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 575-582.
|
| [6] |
Wang Wenjing, Sun Hong, Sun Zhaogang.
Progress of innate immune mechanism activated by Mycobacterium tuberculosis DNA-mediated pattern recognition receptors
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 426-433.
|
| [7] |
Zhang Mengxian, Wang Ni, Huang Fei, Zhou Liping, Zhao Yanlin.
Landscape and prospect of tuberculosis vaccine research and development in China
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 125-129.
|
| [8] |
Dong Jiaxin, Zhao Aihua, Xia Huanzhang, Xu Miao.
Interpretation and reflection on the WHO Preferred Product Characteristics for New Tuberculosis Vaccines
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1016-1020.
|
| [9] |
Yang Zhenggui, Jiang Zeshun, Liu Lan, Han Xue.
Effect of Mycobacterium vaccinae on T Lymphocyte subsets in peripheral blood of HIV patients complicated with latent Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2023, 45(10): 925-931.
|
| [10] |
Wei Shuzhen, Zhao Yong, Lin Jian, Lin Shufang, Dai Zhisong.
Analysis of genotype characteristics and drug resistance of Mycobacterium tuberculosis isolates in Fujian Province from 2017 to 2019
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 73-78.
|
| [11] |
LIU Li-qin, XU Zu-hui, HUANG Yi-sheng, YAO Qi-neng, TAN Yun-hong, ZHOU Lin, XIA Yin-yin, LIU Er-yong, HUANG Guo-jun, BAI Li-qiong, CHENG Shi-ming.
Study on the clinical efficacy of a 4-month treatment program for the initial treatment of smear-negative pulmonary tuberculosis with Mycobacterium vaccae Vaccine immune intervention
[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 125-130.
|
| [12] |
Wu Kunyang, Lu Yewei, Zhang Mingwu, Zhu Yelei, Li Xiangchen, Pan Junhang, Wang Xiaomeng, Wang Wei, Jiang Minmin, Peng Xiaojun, Wang Weixin, Gao Junshun, Liu Zhengwei.
Analysis on characteristic of drug resistance-associated gene mutations and the correlation with genotypes among Mycobacterium tuberculosis isolates in Zhejiang Province
[J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1126-1134.
|
| [13] |
CAO Qian-qian, ZHU Bing-dong, NIU Hong-xia.
Research progress on recombinant protein subunit vaccine of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 970-974.
|
| [14] |
YANG Ting-ting, GAO Qian.
The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data
[J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648.
|
| [15] |
.
Guideline for clinical management of adverse reactions of bacillus Calmette-Guérin
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 532-538.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
